Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–7 of 7 results
Advanced filters: Author: "Teresa K Woodruff" Clear advanced filters

  • Gender inequalities in biomedical research are undermining patient care. In the first of three related pieces, Alison M. Kim, Candace M. Tingen and Teresa K. Woodruff call on journals, funding agencies and researchers to give women parity with men, in studies and in the clinic.

    • Alison M. Kim
    • Candace M. Tingen
    • Teresa K. Woodruff
    Comments & Opinion
    Nature
    Volume: 465, P: 688-689

  • A new analysis of biomedical awards over five decades shows men receive more cash and more respect for their research than women do, report Brian Uzzi and colleagues.

    • Yifang Ma
    • Diego F. M. Oliveira
    • Brian Uzzi
    Comments & Opinion
    Nature
    Volume: 565, P: 287-288

  • Imatinib (trade name Gleevec) preserves fertility in female mice treated with the common chemotherapeutic agent cisplatin. Imatinib seems to block an apoptotic pathway activated by cisplatin in ovarian germ cells (pages 1179–1185). The findings could lead to new ways to protect germ cells from the damaging effects of cancer treatment.

    • Teresa K Woodruff
    News & Views
    Nature Medicine
    Volume: 15, P: 1124-1125

    • Teresa K Woodruff
    Books & Arts
    Nature Medicine
    Volume: 15, P: 1244

  • Although it has been thought that female mammals develop all the eggs they will ever have by the time they are born, new research suggesting otherwise has now sparked a debate.

    • Teresa K Woodruff
    News & Views
    Nature Medicine
    Volume: 14, P: 1190-1191

  • New data show that fertility is possible in women who survive childhood cancer. The challenge is to identify which patients will be left infertile by cancer treatment and who might be able to conceive.

    • Teresa K. Woodruff
    News & Views
    Nature Reviews Endocrinology
    Volume: 9, P: 571-572

  • The number of young cancer survivors is increasing owing to advances in cancer therapeutics, but many face infertility as a result of their treatment. Teresa Woodruff highlights the obstacles to fertility preservation in young cancer patients and describes how the Oncofertility Consortium is addressing these issues by integrating a multidisciplinary network of specialists to assess the impact of treatment, allows research advances in fertility-saving options, and provides patients with the best possible care.

    • Teresa K. Woodruff
    Reviews
    Nature Reviews Clinical Oncology
    Volume: 7, P: 466-475